Recent BHVN News
- Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development • GlobeNewswire Inc. • 06/10/2025 06:00:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 12:40:39 PM
- Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor • PR Newswire (US) • 05/29/2025 11:01:00 AM
- Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for I • PR Newswire (US) • 05/28/2025 07:00:00 PM
- Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors • PR Newswire (US) • 05/28/2025 11:30:00 AM
- FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia • PR Newswire (US) • 05/14/2025 10:43:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 08:17:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 08:08:25 PM
- Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments • PR Newswire (US) • 05/12/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 09:18:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2025 11:59:17 AM
- Biohaven Announces Investment up to $600 Million by Oberland Capital • PR Newswire (US) • 04/28/2025 11:30:00 AM
- Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting • PR Newswire (US) • 04/05/2025 01:00:00 PM
- Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board • GlobeNewswire Inc. • 03/26/2025 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/18/2025 08:48:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/18/2025 08:47:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2025 09:26:30 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/03/2025 09:25:21 PM
- Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300 • PR Newswire (US) • 03/03/2025 12:31:00 PM
- Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results • PR Newswire (US) • 03/03/2025 12:30:00 PM
- Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia • PR Newswire (US) • 02/11/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 04:16:00 PM
- Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Po • PR Newswire (US) • 01/13/2025 04:15:00 PM
- Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs • GlobeNewswire Inc. • 01/13/2025 01:04:12 AM
- Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/07/2025 10:54:00 PM
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM